For Vein Health in Legs and Lower Extremities*
PRODUCT DISCUSSION
PhysioLogics RejuVeinateâ„¢ is a specially formulated blend of herbs and fruit
extracts to promote healthy circulation and vein health in the lower
extremities.*
STRUCTURE AND FUNCTION
- RejuVeinateâ„¢ supplies several active ingredients: The ancient Horse Chestnut tree is native to northern Greece, where its bark, leaves, and seeds were believed to have health benefits.
- This unique formula contains Butcher's Broom to support venous tone by promoting vein elasticity.* Bilberry contains over 15 naturally-occurring anthocyanosides, flavonoids that have beneficial properties.
CLINICAL EVIDENCE
- A total of 87 study subjects received tablets standardized to contain 50 mg of aescin (the active ingredient in Horse Chestnut extract) twice per day for 8 consecutive weeks. Leg vein health was significantly improved at the end of the study as compared to baseline. (Dickson et al, 2004)
- In a randomized double-blind placebo-controlled study, 148 women received either 72-75 mg dry extract of Butcher's broom per day or placebo for 12 weeks. The subjects receiving Butcher's broom experienced significant (p<0.001) improvements in leg comfort and indications of vein elasticity compared with placebo. (Vanscheidt et al, 2002)
SUMMARY
PhysioLogics RejuVeinateâ„¢ delivers a special blend of herbs and fruit extracts
to help support the structural integrity of the vascular system, especially in
the legs.*
SUGGESTED DOSAGE
For adults, take two (2) capsules one to two times daily, preferably with a meal
or follow the advice of a health care professional.
REFERENCES
Dickson S, Gallagher J, McIntyre L, et al. An open study to assess the safety
and efficacy of aesculus hippocastanum tablets (Aesculaforce 50 mg) in the
treatment of chronic venous insufficiency. J Herb Pharmacother. 2004;4:19-32.
Vanscheidt W, Jost V, Wolna P, et al. Efficacy and safety of a butcher's broom preparation (ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency. Arzneimittelforschung. 2002;4:243-50.
Click
here for Label Information in PDF format
Close PDF window to return to store
